IgG4 plasma cells in inflammatory myofibroblastic tumor: Inflammatory marker or pathogenic link

Modern Pathology

Volumn 24, Issue 4, 2011, Pages 606-612

  Saab, Shahrazadb T ^a   Hornick, Jason L ^b   Fletcher, Christopher D ^b   Olson, Sandra J ^a   Coffin, Cheryl M ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ALK; IgG4 related sclerosing disease; inflammatory myofibroblastic tumor; inflammatory pseudotumor; plasma cells; sarcoma

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; ANAPLASTIC LYMPHOMA KINASE 1; ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; PREDNISONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CELL AGGREGATION; CHILD; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DIAGNOSTIC TEST; DISEASE SEVERITY; FEMALE; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOGLOBULIN G4 RELATED SCLEROSING DISEASE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; INFANT; LYMPHOID CELL; MALE; OBLITERATIVE PHLEBITIS; PATHOGENESIS; PHLEBITIS; PLASMA CELL; PLASMA CELL GRANULOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SCLEROSIS; SOLITARY FIBROUS TUMOR; SYMPTOM;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; DIAGNOSIS, DIFFERENTIAL; FEMALE; GRANULOMA, PLASMA CELL; HUMANS; IMMUNOGLOBULIN G; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MYOFIBROBLASTS; PLASMA CELLS; PREDICTIVE VALUE OF TESTS; RECEPTOR PROTEIN-TYROSINE KINASES; SCLERODERMA, SYSTEMIC; YOUNG ADULT;

EID: 79953314005     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.226     Document Type: Article

References (30)

1. Griffin CA, Hawkins AL, Dvorak C, et al. Recurrent involvement of 2p23 in inflammatory myofibroblastic tumors. Cancer Res 1999;59:2776-2780. (Pubitemid 29283106)
2. Lawrence B, Perez-Atayde A, Hibbard MK, et al. TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors. Am J Pathol 2000;157: 377-384. (Pubitemid 30627557)
3. Coffin CM, Patel A, Perkins S, et al. ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor. Mod Pathol 2001;14:569-576. (Pubitemid 32554081)
4. Debelenko LV, Arthur DC, Pack SD, et al. Identification of CARS-ALK fusion in primary and metastatic lesions of an inflammatory myofibroblastic tumor. Lab Invest 2003;83:1255-1265. (Pubitemid 37140310)
5. Debiec-Rychter M, Marynen P, Hagemeijer A, et al. ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003;38:187-190. (Pubitemid 37093436)
6. Coffin CM, Fletcher JA. Inflammatory myofibroblastic tumour. In: Fletcher CDM, Unni KK, Mertens F, (eds). Pathology and genetics of tumours of soft tissue and bone. World health organization classification of tumours. IARC Press: Lyon, 2002, pp 91-93.
7. Tang TT, Segura AD, Oechler HW, et al. Inflammatory myofibrohistiocytic proliferation simulating sarcoma in children. Cancer 1990;65:16-34.
8. Kutluk T, Emir S, Karnak I, et al. Mesentric inflammatory psuedotumor: usual presentation with leukemoid reaction and massive calcified mass. J Pediatr Hematol Oncol 2002;24:158-159. (Pubitemid 34150560)
9. Sciot R, Dal Cin P, Fletcher CD, et al. Inflammatory myofibroblastic tumor of bone: report of two cases with evidence of clonal chromosomal changes. Am J Surg Pathol 1997;21:1166-1172. (Pubitemid 27422315)
10. Ramachandra S, Hollowood K, Bisceglia M, et al. Inflammatory pseudotumour of soft tissues: a clinicopathological and immunohistochemical analysis of 18 cases. Histopathology 1995;27:313-323.
11. Hausler M, Schaade L, Ramaekers VT, et al. Inflammatory pseudotumors of the central nervous system: report of 3 cases and a literature review. Hum Pathol 2003;34:253-262. (Pubitemid 36356678)
12. Rabban JT, Zaloudek CJ, Shekitka KM, et al. Inflammatory myofibroblastic tumor of the uterus: a clinicopathologic study of 6 cases emphasizing distinction from aggressive mesenchymal tumors. Am J Surg Pathol 2005;29:1348-1355. (Pubitemid 41368771)
13. Gleason BC, Hornick JL. Inflammatory myofibroblastic tumours: where are we now? J Clin Pathol 2008;61: 428-437. (Pubitemid 351518223)
14. Kamisawa T, Funata N, Hayashi Y, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003;38:982-984. (Pubitemid 37455786)
15. Kamisawa T, Nakajima H, Egawa N, et al. IgG4-related sclerosing disease incorporating sclerosing pancreatitis, cholangitis, sialadenitis and retroperitoneal fibrosis with lymphadenopathy. Pancreatology 2006;6: 132-137.
16. Cheuk W, Lee KC, Chong LY, et al. IgG4-related sclerosing disease: a potential new etiology of cutaneous pseudolymphoma. Am J Surg Pathol 2009;33: 1713-1719.
17. Zen Y, Inoue D, Kitao A, et al. IgG4-related lung and pleural disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2009;33:1886-1893.
18. Coffin CM, Hornick JL, Fletcher CDM. Inflammatory myofibroblastic tumor comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases. Am J Surg Pathol 2007;31:509-520. (Pubitemid 46569034)
19. Coffin CM, Watterson J, Priest JR, et al. Extrapulmonary myofibroblastic tumor (inflammatory pseudotumor): a clinicopathologic and immunohitochemical study of 84 cases. Am J Surg Pathol 1995;19:859-872.
20. Sepehr A, Mino-Kenudson M, Ogawa F, et al. IgG4+to IgG+plasma cells ratio of ampulla can help differentiate autoimmune pancreatitis from other 'mass forming' pancreatic lesions. Am J Surg Pathol 2008;32:1770-1779.
21. Bridge JA, Kanamori M, Ma Z, et al. Rusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory fibroblastic tumor. Am J Pathol 2001; 159:411-415. (Pubitemid 32751070)
22. Ma Z, Hill DA, Collins MH, et al. Fusion of ALK to the Ran-binding protein 2 (RANBP2) gene in inflammatory myofibroblastic tumor. Genes Chromosomes Cancer 2003;37:98-105. (Pubitemid 36417927)
23. Cole B, Zhou H, McAllister N, et al. Inflammatory myofibroblastic tumor with thrombocytosis and a unique chromosomal translocation with ALK rearrangemen. Arch Pathol Lab Med 2006;130:1042-1045. (Pubitemid 44061437)
24. Chan SK, Cheuk W, Chan KT, et al. IgG4-related sclerosing pachymeningitis: a previously unrecognized form of central nervous system involvement in IgG4-related sclerosing disease. Am J Surg Pathol 2009;33:1249-1252.
25. Gelrud A, Freedman SD. Autoimmune pancreatitis. J Gastrointestinal Surg 2005;9:2-5. (Pubitemid 40037864)
26. Deshpande V, Chicano S, Finkelberg D, et al. Autoimmune pancreatitis: a systemic immune complex mediated disease. Am J Surg Pathol 2006;30: 1537-1545. (Pubitemid 44808790)
27. Zen Y, Kitagawa S, Minato H, et al. IgG4-positive plasma cells in inflammatory pseudotumor (plasma cell granuloma) of the lung. Hum Pathol 2005;36:710-717. (Pubitemid 41112024)
28. Kamisawa T, Tu Y, Nakajima H, et al. Usefulness of biopsying the major duodenal papilla to diagnose autoimmune pancreatitis: a prospective study using IgG4-immunostaining. World J Gastroenterol 2006;12: 2031-2033.
29. Kitagawa S, Zen Y, Harada K, et al. Abundant IgG4-positive plasma cell infiltration characterizes chronic sclerosing sialadenitis (Kuttner's tumor). Am J Surg Pathol 2005;29:783-791. (Pubitemid 40734427)
30. Yamamoto H, Yamaguchi H, Aishima S, et al. Inflammatory myofibroblastic tumor versus IgG4-related sclerosing disease and inflammatory pseudotumor: a comparative clinicopathologic study. Am J Surg Pathol 2009;33:1330-1340.